Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting

Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891 · see citing works

Translocation of inhaled ultrafine particles to the brain

Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606 · see citing works

Sniffing neuropeptides: A transnasal approach to the human brain

Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356 · see citing works

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial

Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253 · see citing works

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations

Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239 · see citing works

Intranasal delivery of biologics to the central nervous system

Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214 · see citing works

Chitosan-modifications and applications: Opportunities galore

Mourya, V. K., & Inamdar, N. N. (2008) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2008.03.002 · Cited by 1,150 · see citing works

Nasal drug delivery—possibilities, problems and solutions

Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,107 · see citing works

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050 · see citing works

Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration

Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958 · see citing works

Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics.

Bates, D. V., Fish, B., Hatch, T. F., Mercer, T. T., & Morrow, P. E. (1966) · PubMed · Cited by 771 · see citing works

Nanoparticles for direct nose-to-brain delivery of drugs

Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734 · see citing works

Intranasal insulin improves memory in humans

Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H. L., Born, J., & Kern, W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.04.003 · Cited by 699 · see citing works

Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus Barrier

Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R. A., & Hanes, J. S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597 · see citing works

Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species

Johnston, M., Zakharov, A., Papaiconomou, C., Salmasi, G., & Armstrong, D. (2004) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-1-2 · Cited by 572 · see citing works

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435 · see citing works

Biomédical applications of nanotechnology — implications for drug targeting and gene therapy

Davis, S. S. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01036-6 · Cited by 417 · see citing works

Strategy for effective brain drug delivery

Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.003 · Cited by 415 · see citing works

Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies

Seju, U., Kumar, A., & Sawant, K. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.07.025 · Cited by 367 · see citing works

Intranasal delivery of cells to the brain

Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., Burkhardt, U. E., Proksch, B., Verleysdonk, S., Ayturan, M., et al. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.02.001 · Cited by 355 · see citing works

Drug transfer through mucus

Khanvilkar, K. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00115-6 · Cited by 333 · see citing works

Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?

García-García, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314 · see citing works

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

Wang, X., Chi, N., & Tang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.005 · Cited by 307 · see citing works

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns

Göppert, T. M., & Müller, R. H. (2005) · Journal of drug targeting · doi:10.1080/10611860500071292 · Cited by 299 · see citing works

Lectin-conjugated PEG–PLA nanoparticles: Preparation and brain delivery after intranasal administration

Gao, X., Tao, W., Lü, W., Zhang, Q., Zhang, Y., Jiang, X., & Fu, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.038 · Cited by 295 · see citing works

Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Bernhard, F. P., Verleysdonk, S., Buadze, M., Lourhmati, A., Klopfer, T., Schaumann, F. T., Schmid, B., et al. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1130 · Cited by 261 · see citing works

PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications

Casettari, L., Vllasaliu, D., Castagnino, E., Stolnik, S., Howdle, S. M., & Illum, L. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.10.001 · Cited by 259 · see citing works

Nasal delivery systems and their effect on deposition and absorption

Kublik, H., & Vidgren, M. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00067-7 · Cited by 249 · see citing works

Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway

Chen, X., Fawcett, J. R., Rahman, Y., Ala, T. A., & Frey, W. H. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1102 · Cited by 247 · see citing works

Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242 · see citing works

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

Gao, X., Wu, B., Zhang, Q., Chen, J., Zhu, J., Zhang, W., Rong, Z., Chen, H., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.026 · Cited by 207 · see citing works

CNS Drug Delivery Systems: Novel Approaches

Pathan, S., Iqbal, Z., Zaidi, S., Talegaonkar, S., Vohra, D., Jain, G., Azeem, A., Jain, N., Lalani, J., Khar, R., et al. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158355 · Cited by 193 · see citing works

Central nervous system effects of intranasally administered insulin during euglycemia in men.

Kern, W., Jan Born, A., Schreiber, H., & Fehm, H. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192 · see citing works

Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

Patel, S., Chavhan, S. S., Soni, H., Babbar, A. K., Mathur, R., Mishra, A. K., & Sawant, K. K. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523787 · Cited by 187 · see citing works

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.427 · Cited by 181 · see citing works

Intranasal insulin delivery and therapy1Abbreviations: α-CD, α-cyclodextrin; β-CD, β-cyclodextrin; γ-CD, γ-cyclodextrin; AUC, area under the plasma/serum concentration versus time curve; Cmax, maximum or peak plasma/serum concentration; Cmin, minimum plasma/serum concentration; DDPC, didecanoyl-L-α-phosphatidylcholine; DM-β-CD, dimethyl-β-cyclodextrin; EDTA, ethylenediaminetetraacetic acid; FITC, fluorescein isothiocyanate; HLB, hydrophile–lipophile balance; hGH, human growth hormone; HP-β-CD, hydroxy-propyl-β-cyclodextrin; HPC, hydroxypropylcellulose; HSA, human serum albumin; Hyaff 11, hyaluronic acid ester; IDDM, insulin-dependent diabetes mellitus; Ig, immunoglobulin; Laureth-9, polyoxyethylene-9-lauryl ether; LPC, lysophosphatidylcholine; LPG, lysophosphatidylglycerol; MCC, microcrystalline cellulose; MTR, mucociliary transport rate; NIDDM, non-insulin-dependent diabetes mellitus; PC, phosphatidylcholine; RAMEB, randomly methylated β-cyclodextrin; SDC, sodium deoxycholate; SGC, sodium glycocholate; STDHF, sodium taurodihydrofusidate; 99mTc, 99mtechnetium; TER, transepithelial resistance.1

Hinchcliffe, M., & Illum, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00073-8 · Cited by 180 · see citing works

Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

Kumar, M., Misra, A., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802476504 · Cited by 179 · see citing works

Nasal Drug Delivery System-Factors Affecting and Applications

Jadhav, K. R., Gambhire, M., Shaikh, I. M., Kadam, V., & Pisal, S. (2007) · Current Drug Therapy · doi:10.2174/157488507779422374 · Cited by 177 · see citing works

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions

Schiöth, H. B., Craft, S., Brooks, S. J., Frey, W. H., & Benedict, C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8229-6 · Cited by 168 · see citing works

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Benedict, C., Frey, W. H., Schiöth, H. B., Schultes, B., Jan Born, A., & Hallschmid, M. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.026 · Cited by 158 · see citing works

Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation

Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 158 · see citing works

Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water Maze

Gozes, I., Giladi, E., Pinhasov, A., Bardea, A., & Brenneman, D. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39336-x · Cited by 157 · see citing works

Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration

Xia, H., Gao, X., Gu, G., Liu, Z., Zeng, N., Hu, Q., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.004 · Cited by 152 · see citing works

Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion

Liu, X., Fawcett, J. R., Thorne, R. G., & Frey, W. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01982-6 · Cited by 150 · see citing works

Intranasal delivery: An approach to bypass the blood brain barrier

Talegaonkar, S., & Mishra, P. (2004) · Bioline International (Bioline International) · Cited by 148 · see citing works

Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

Banks, W. A., During, M. J., & Niehoff, M. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063222 · Cited by 144 · see citing works

Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach

Pardeshi, C. V., Rajput, P. V., Belgamwar, V. S., Tekade, A. R., & Surana, S. J. (2013) · Drug Delivery · doi:10.3109/10717544.2012.752421 · Cited by 141 · see citing works

Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats

Khan, S., Patil, K., Bobade, N. N., Yeole, P. G., & Gaikwad, R. V. (2009) · Journal of drug targeting · doi:10.3109/10611860903386938 · Cited by 138 · see citing works

Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam

Li, L., Nandi, I., & Kim, K. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00029-7 · Cited by 136 · see citing works

The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug.

Sakane, T., Akizuki, M., Yamashita, S., NADAI, T., Hashida, M., & Sezaki, H. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.2456 · Cited by 135 · see citing works

Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans

Pietrowsky, R., Strüben, C., Mölle, M., Fehm, H. L., & Jan Born, A. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00180-8 · Cited by 133 · see citing works

Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration

Ali, J., Ali, M., Baboota, S., Sahni, J. K., Ramassamy, C., Dao, L. H., & Bhavna (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164108 · Cited by 130 · see citing works

Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone

Kumar, M., Pathak, K., & Misra, A. R. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802363704 · Cited by 125 · see citing works

Microparticles for intranasal immunization

Vajdy, M., & O’Hagan, D. T. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00167-3 · Cited by 115 · see citing works

The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4–10Decreases Body Fat in Humans1

Fehm, H. L., Smolnik, R., Kern, W., McGregor, G. P., Bickel, U., & Jan Born, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7298 · Cited by 113 · see citing works

Recent progress in protein and peptide delivery by noninvasive routes.

Wearley, L. L. (1991) · PubMed · Cited by 109 · see citing works

Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145565 · Cited by 102 · see citing works

Clearance of Inhaled Particles From the Human Nose

Proctor, D. F. (1973) · Archives of Internal Medicine · doi:10.1001/archinte.1973.00320070128014 · Cited by 98 · see citing works

Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy

Jain, R. D., Nabar, S., Dandekar, P. P., & Patravale, V. B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0041-x · Cited by 97 · see citing works

Levels of dopamine in blood and brain following nasal administration to rats

Dahlin, M., Jansson, B., & Björk, E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00151-8 · Cited by 96 · see citing works

Intranasal delivery of stem cells to the brain

Jiang, Y., Zhu, J., Xu, G., & Liu, X. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566267 · Cited by 89 · see citing works

A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin

Pietrowsky, R., Thiemann, A., Kern, W., Fehm, H. L., & Jan Born, A. (1996) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00012-1 · Cited by 86 · see citing works

Mucoadhesivein situnasal gelling drug delivery systems for modulated drug delivery

Singh, R. M. P., Kumar, A., & Pathak, K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.746659 · Cited by 82 · see citing works

Brain distribution of ribavirin after intranasal administration

Colombo, G., Lorenzini, L., Zironi, E., Galligioni, V., Sonvico, F., Balducci, A. G., Pagliuca, G., Giuliani, A., Calzà, L., & Scagliarini, A. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.09.012 · Cited by 80 · see citing works

Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug

Sakane, T., Akizuki, M., Yamashita, S., Sezaki, H., & NADAI, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03817.x · Cited by 79 · see citing works

Aerosol distribution in the nose.

Mygind, N., & Vesterhauge, S. (1978) · PubMed · Cited by 78 · see citing works

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery

Oh, Y., Kim, J., Hwang, T. S., Ko, J. J., Kim, J. M., Yang, J.-S., & Kim, C. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00188-8 · Cited by 69 · see citing works

Bioavailability of intranasal drug delivery system

Bhise, S., Yadav, A. V., Avachat, A. M., & Malayandi, R. (2008) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.45032 · Cited by 69 · see citing works

Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases

Huang, B. Y., Tabata, Y., & Gao, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.034 · Cited by 66 · see citing works

Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan

Pardeshi, C. V., Rajput, P. V., Belgamwar, V. S., & Tekade, A. R. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.630106 · Cited by 58 · see citing works

Lysosomal enzyme can bypass the blood–brain barrier and reach the CNS following intranasal administration

Wolf, D. A., Hanson, L. R., Aronovich, E. L., Nan, Z., Low, W. C., Frey, W. H., & McIvor, R. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.02.006 · Cited by 58 · see citing works

Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders

Hallschmid, M., Benedict, C., Schultes, B., Perras, B., Fehm, H., Kern, W., & Jan Born, A. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.06.012 · Cited by 56 · see citing works

In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain

Liu, Q., Shao, X., Chen, J., Shen, Y., Feng, C., Gao, X., Zhao, Y., Li, J., Zhang, Q., & Jiang, X. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.12.003 · Cited by 53 · see citing works

Stem cell transplantation for neurometabolic and neurodegenerative diseases

Shihabuddin, L. S., & Aubert, I. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.015 · Cited by 49 · see citing works

Evidence for sialyl glycoconjugates as receptors for Bordetella bronchiseptica on swine nasal mucosa

Ishikawa, H., & ISAYAMA, Y. (1987) · Infection and Immunity · doi:10.1128/iai.55.7.1607-1609.1987 · Cited by 46 · see citing works

Nasal Clearance in Health and Disease

Illum, L. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.92 · Cited by 42 · see citing works

Intranasal delivery of growth differentiation factor 5 to the central nervous system

Hanson, L. R., Fine, J. M., Hoekman, J., Nguyen, T. M., Burns, R. B., Martinez, P. M., Pohl, J., & Frey, W. H. (2012) · Drug Delivery · doi:10.3109/10717544.2012.657720 · Cited by 32 · see citing works

Evidence of antibody production in the rat cervical lymph nodes after antigen administration into the cerebrospinal fluid

Walter, B. A., Valera, V., Takahashi, S., Matsuno, K., & Ushiki, T. (2006) · Archivum histologicum japonicum · doi:10.1679/aohc.69.37 · Cited by 32 · see citing works

Bioavailability of intranasal drug delivery system

Bhise, S. B., Yadav, A. V., Avachat, A. M., et al. (2008) · Asian Journal of Pharmaceutics · doi:10.22377/ajp.v2i4.203 · Cited by 32 · see citing works

Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats

Chen, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.013 · Cited by 20 · see citing works

The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract.

Rf, H., BLACK, A. E., & Walsh, M. T. (1970) · PubMed · Cited by 12 · see citing works

Preparation and Evaluation of Microemulsion Based Formulations for Rapid-Onset Intranasal Delivery of Zonisamide

Shahiwala, A., & Dash, D. (2010) · Advanced Science Letters · doi:10.1166/asl.2010.1149 · Cited by 11 · see citing works

The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems

Mistry, A. (2009) · Nottingham ePrints (University of Nottingham) · Cited by 5 · see citing works

Evaluation of intranasal delivery route of drug administration for brain targeting

Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 756 · see citing works

International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance

Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665 · see citing works

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604 · see citing works

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 499 · see citing works

Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy

Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 440 · see citing works

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa

Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447 · see citing works

Progress in brain targeting drug delivery system by nasal route

Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402 · see citing works

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357 · see citing works

Quantitative analysis of drug delivery to the brain via nasal route

Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 345 · see citing works

Strategies for transporting nanoparticles across the blood–brain barrier

Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308 · see citing works

Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting

Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306 · see citing works

Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies

Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 304 · see citing works

Stimuli-responsive In situ gelling system for nose-to-brain drug delivery

Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U. D., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 299 · see citing works

The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview

Djupesland, P. G., Messina, J. C., & Mahmoud, R. A. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.41 · Cited by 297 · see citing works

Nanoemulsions for “Nose-to-Brain” Drug Delivery

Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works

Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors

Jeong, S., Jang, J.-H., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 259 · see citing works

Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy

Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.01.031 · Cited by 239 · see citing works

Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges

Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 216 · see citing works

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 219 · see citing works

Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles

Patel, A., Patel, M., Yang, X., & Mitra, A. K. (2014) · Protein and Peptide Letters · doi:10.2174/0929866521666140807114240 · Cited by 209 · see citing works

Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity

Raj, R., Wairkar, S., Sridhar, V., & Gaud, R. S. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.056 · Cited by 205 · see citing works

Cyclodextrin‐Based Formulations: A Non‐Invasive Platform for Targeted Drug Delivery

Muankaew, C., & Loftsson, Þ. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12917 · Cited by 204 · see citing works

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress

Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/48/485102 · Cited by 192 · see citing works

Nanoemulsions in Drug Delivery: Formulation to Medical Application

Tayeb, H. H., & Sainsbury, F. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0088 · Cited by 190 · see citing works

Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

Upton, D. H., Ung, C., George, S. M., Tsoli, M., Kavallaris, M., & Ziegler, D. S. (2022) · Theranostics · doi:10.7150/thno.69682 · Cited by 182 · see citing works

Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson’s Disease Model

Gaba, B., Khan, T. M., Haider, M. F., Alam, T., Baboota, S., Parvez, S., & Ali, J. (2019) · BioMed Research International · doi:10.1155/2019/2382563 · Cited by 181 · see citing works

Nose-to-brain peptide delivery – The potential of nanotechnology

Samaridou, E., & Alonso, M. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 178 · see citing works

Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders

Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 172 · see citing works

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives

Hong, S.-S., Oh, K. T., Choi, H., & Lim, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100540 · Cited by 162 · see citing works

Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion

Long, Y., Yang, Q., Yan, X., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104795 · Cited by 157 · see citing works

Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro

Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., & Koester, L. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.055 · Cited by 157 · see citing works

Administration of Caffeine in Alternate Forms

Wickham, K. A., & Spriet, L. L. (2018) · Sports Medicine · doi:10.1007/s40279-017-0848-2 · Cited by 154 · see citing works

Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

Gandhi, S. J., Shastri, D. H., Shah, J., Nair, A. B., & Jacob, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040481 · Cited by 146 · see citing works

Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses

Khan, A. S., Imam, S. S., Aqil, M., Ahad, A., Sultana, Y., Ali, A., & Khan, K. M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00586 · Cited by 144 · see citing works

Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges

Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 146 · see citing works

Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders

Awad, R., Avital, A., & Sosnik, A. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.003 · Cited by 144 · see citing works

Nose-to-brain delivery of insulin enhanced by a nanogel carrier

Picone, P., Sabatino, M. A., Ditta, L. A., Amato, A., San Biagio, P. L., Mulè, F., Giacomazza, D., Dispenza, C., & Di Carlo, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.040 · Cited by 148 · see citing works

Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities

Ovais, M., Zia, N., Ahmad, I., Khalil, A., Raza, A., Ayaz, M., Sadiq, A., Ullah, F., & Shinwari, Z. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00284 · Cited by 120 · see citing works

Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview

Musumeci, T., Bonaccorso, A., & Puglisi, G. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030118 · Cited by 135 · see citing works

Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety

Chatzitaki, A., Jesus, S., Karavasili, C., Andreadis, D., Fatouros, D. G., & Borges, O. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119776 · Cited by 134 · see citing works

Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion

Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124 · see citing works

Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Chen, T. C., da Fonseca, C. O., & Schönthal, A. H. (2015) · Europe PMC (PubMed Central) · Cited by 119 · see citing works

Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies

Gadhave, D. G., & Kokare, C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1576724 · Cited by 117 · see citing works

Ghrelin attenuates oxidative stress and neuronal apoptosis via GHSR-1α/AMPK/Sirt1/PGC-1α/UCP2 pathway in a rat model of neonatal HIE

Huang, J., Liu, W., Doycheva, D., Gamdzyk, M., Lu, W.-T., Tang, J.-P., & Zhang, J. H. (2019) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2019.07.001 · Cited by 111 · see citing works

Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery

Salatin, S., Barar, J., Barzegar-Jalali, M., Adibkia, K., Milani, M. A., & Jelvehgari, M. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0782-0 · Cited by 114 · see citing works

Research progress in brain-targeted nasal drug delivery

Huang, Q., Chen, X., Yu, S., Gong, G., & Shu, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1341295 · Cited by 114 · see citing works

Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review

Kulkarni, A. D., Vanjari, Y. H., Sancheti, K. H., Belgamwar, V. S., Surana, S. J., & Pardeshi, C. V. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1020809 · Cited by 114 · see citing works

Formulation and device design to increase nose to brain drug delivery

Warnken, Z. N., Smyth, H. D. C., Watts, A. B., Weitman, S., Kuhn, J. G., & Williams, R. O. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.05.003 · Cited by 113 · see citing works

Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease

Akel, H., Ismail, R., & Csóka, I. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.12.014 · Cited by 110 · see citing works

Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders

Rassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., & Giunchedi, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010008 · Cited by 107 · see citing works

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Lü, Z., Shen, J., Yang, H. J., Wang, J., Zhao, R., Zhang, T.-L., Guo, J. R., & Zhang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01298-z · Cited by 108 · see citing works

Microemulsion-Based Media in Nose-to-Brain Drug Delivery

Froelich, A., Osmałek, T. Z., Jadach, B., Puri, V., & Michniak‐Kohn, B. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020201 · Cited by 107 · see citing works

Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application

Tanaka, A., Furubayashi, T., Arai, M., Inoue, D., Kimura, S., Kiriyama, A., Kusamori, K., Katsumi, H., Yutani, R., Sakane, T., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00991 · Cited by 104 · see citing works

The search for novel analgesics: targets and mechanisms

Yaksh, T. L., Woller, S. A., Ramachandran, R., & Sorkin, L. S. (2015) · F1000Prime Reports · doi:10.12703/p7-56 · Cited by 100 · see citing works

Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats

Pang, Y., Lin, S., Wright, C., Shen, J., Carter, K., Bhatt, A., & Fan, L.-W. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.020 · Cited by 99 · see citing works

ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-133 · Cited by 96 · see citing works

Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine

Chang, J., Chao, Y., Chang, H.-S., Wu, Y., Chang, H.-J., Lin, Y.-S., Cheng, W., Lin, T., & Liu, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-90094-w · Cited by 99 · see citing works

Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study

Salem, H. F., Kharshoum, R. M., Abou‐Taleb, H. A., & Naguib, D. M. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1353-8 · Cited by 96 · see citing works

Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

Ja, T., Quispe, R. C., Khan, F., & Новак (2020) · PubMed · Cited by 96 · see citing works

The Olfactory System of Zebrafish as a Model for the Study of Neurotoxicity and Injury: Implications for Neuroplasticity and Disease

Calvo‐Ochoa, E., & Byrd-Jacobs, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071639 · Cited by 95 · see citing works

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route

El-Enin, H. A. A., Elkomy, M. H., Naguib, I. A., Ahmed, M. F. E., Alsaidan, O. A., Alsalahat, I., Ghoneim, M. M., & Eid, H. M. (2022) · Pharmaceuticals · doi:10.3390/ph15030281 · Cited by 95 · see citing works

Nasalin-situgels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization

Ravi, P. R., Aditya, N., Patil, S. B., & Cherian, L. (2013) · Drug Delivery · doi:10.3109/10717544.2013.860501 · Cited by 95 · see citing works

Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation

Pardeshi, C. V., Belgamwar, V. S., Tekade, A. R., & Surana, S. J. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-4965-7 · Cited by 95 · see citing works

Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650

Ladel, S., Schlossbauer, P., Flamm, J., Luksch, H., Mizaikoff, B., & Schindowski, K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080367 · Cited by 94 · see citing works

How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods

Salade, L., Wauthoz, N., Goole, J., & Amighi, K. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.026 · Cited by 92 · see citing works

Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs

Mignani, S. M., Shi, X., Karpus, A. O., & Majoral, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112905 · Cited by 92 · see citing works

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 94 · see citing works

Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development

Chen, T. C., da Fonseca, C. O., & Schönthal, A. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123905 · Cited by 88 · see citing works

Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

Witika, B. A., Poka, M., Demana, P. H., Matafwali, S. K., Melamane, S., Khamanga, S. M., & Makoni, P. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040836 · Cited by 82 · see citing works

Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule

Salem, L. H., El-Feky, G. S., Fahmy, R. H., El-Gazayerly, O. N., & Abdelbary, A. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.04.007 · Cited by 79 · see citing works

Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease

Wong, L. R., & Ho, P. C. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12836 · Cited by 79 · see citing works

The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

Qiu, Y., Huang, S., Peng, L., Yang, L., Zhang, G., Liu, T., Yan, F., & Peng, X. (2025) · MedComm · doi:10.1002/mco2.70213 · Cited by 90 · see citing works

Nose to brain delivery of astaxanthin-loaded solid lipid nanoparticles: fabrication, radio labeling, optimization and biological studies

Bhatt, P. C., Srivastava, P., Pandey, P., Khan, W., & Panda, B. P. (2016) · RSC Advances · doi:10.1039/c5ra19113k · Cited by 77 · see citing works

A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation

Akel, H., Ismail, R., Katona, G., Sabir, F., Ambrus, R., & Csóka, I. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120724 · Cited by 78 · see citing works

Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel

Wang, J. T.-W., Rodrigo, A. C., Patterson, A. K., Hawkins, K., Aly, M. M. S., Sun, J., Al‐Jamal, K. T., & Smith, D. K. (2021) · Advanced Science · doi:10.1002/advs.202101058 · Cited by 75 · see citing works

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease

Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 76 · see citing works

Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes

Chatzidaki, M. D., & Mitsou, E. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030337 · Cited by 74 · see citing works

Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson’s disease

Uppuluri, C. T., Ravi, P. R., & Dalvi, A. V. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120881 · Cited by 73 · see citing works

Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs

Gonçalves, V. S. S., Matias, A. A., Poejo, J., Serra, T., & Duarte, C. M. M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.086 · Cited by 72 · see citing works

Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies

Salatin, S., Barar, J., Barzegar-Jalali, M., Adibkia, K., & Jelvehgari, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.031 · Cited by 72 · see citing works

Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery

Shringarpure, M., Gharat, S., Momin, M. M., & Omri, A. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1823965 · Cited by 70 · see citing works

Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA

Borrajo, M. L., & Alonso, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01086-2 · Cited by 70 · see citing works

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles

Chung, E. P., Cotter, J. D., Prakapenka, A. V., Cook, R. L., DiPerna, D. M., & Sirianni, R. W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020093 · Cited by 69 · see citing works

Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

Montegiove, N., Calzoni, E., Emiliani, C., & Cesaretti, A. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13030125 · Cited by 70 · see citing works

Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

Patharapankal, E. J., Ajiboye, A. L., Mattern, C., & Trivedi, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010066 · Cited by 69 · see citing works

Design and Efficacy of Nanogels Formulations for Intranasal Administration

Aderibigbe, B. A., & Naki, T. (2018) · Molecules · doi:10.3390/molecules23061241 · Cited by 69 · see citing works

Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination

Salem, H. F., Kharshoum, R. M., Abou‐Taleb, H. A., & Naguib, D. M. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1608553 · Cited by 68 · see citing works

RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery

Hao, R., Sun, B., Yang, L., Ma, C., & Li, S. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1760960 · Cited by 67 · see citing works

Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke

Li, R., Huang, Y., Chen, L., Zhou, H.-H., Zhang, M., Chang, L., Shen, H. Y., Zhou, M., Su, P., & Zhu, D. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.10.013 · Cited by 67 · see citing works

Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors

Triarico, S., Maurizi, P., Mastrangelo, S., Attinà, G., Capozza, M. A., & Ruggiero, A. (2019) · Cancers · doi:10.3390/cancers11060824 · Cited by 67 · see citing works

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 66 · see citing works

Nose-to-brain delivery of antipsychotics using nanotechnology: a review

Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 65 · see citing works

Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 65 · see citing works

Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma

Gadhave, D. G., Gorain, B., Tagalpallewar, A. A., & Kokare, C. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.013 · Cited by 64 · see citing works

Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies

Patel, H., Gandhi, P. A., Chaudhari, P. S., Desai, B. V., Desai, D. T., Dedhiya, P. P., Maulvi, F. A., & Vyas, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102533 · Cited by 63 · see citing works

Advancements in drug delivery methods for the treatment of brain disease

Partridge, B. R., Eardley, A., Morales, B. E., Campelo, S. N., Lorenzo, M., Mehta, J., Kani, Y., Mora, J. K. G., Campbell, E.-O. Y., Arena, C. B., et al. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1039745 · Cited by 50 · see citing works

Lipid-based nanoparticles via nose-to-brain delivery: a mini review

Xinchen, Y., Jing, T., & Jiaoqiong, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1214450 · Cited by 62 · see citing works

Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.

da Fonseca, C. O., Teixeira, R. M., Silva, J. C. T., Fischer, J. D. S. D. G., Meirelles, O. C., Landeiro, J. A., & Quírico‐Santos, T. (2013) · PubMed · Cited by 62 · see citing works

Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs

Pardeshi, C. V., & Belgamwar, V. S. (2019) · Materials Technology · doi:10.1080/10667857.2019.1674522 · Cited by 61 · see citing works

Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application

Ahmad, J., Rizwanullah, M., Amin, S., Warsi, M. H., Ahmad, M. Z., & Barkat, M. A. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200719003304 · Cited by 60 · see citing works

Nanotechnology-Mediated Nose-to-Brain Drug Delivery for Neurodegenerative Disorders

Pardeshi, C. V., Belgamwar, V. S., & Surana, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_6 · Cited by 7 · see citing works

Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges

Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 146 · see citing works

Strategies for enhanced direct nose-to-brain drug delivery

Madav, Y., & Wairkar, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00014-x · Cited by 4 · see citing works

Applications of direct nose-to-brain drug delivery in medicine and pharmacy

Shevalkar, G. B., Prajapati, M. K., Pai, R. V., & Mali, K. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00011-4 · Cited by 1 · see citing works

Gel-based delivery of neurotherapeutics via naso-brain pathways

Mahajan, H. S., & Patil, P. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00026-6 · Cited by 4 · see citing works